Home > Updated perspectives on the neurobiology of substance use disorders using neuroimaging.

Murnane, Kevin S and Edinoff, Amber N and Cornett, Elyse M and Kaye, Alan D (2023) Updated perspectives on the neurobiology of substance use disorders using neuroimaging. Substance Abuse and Rehabilitation, 14, pp. 99-111. doi: 10.2147/SAR.S362861.

External website: https://www.dovepress.com/updated-perspectives-on-...

Substance use problems impair social functioning, academic achievement, and employability. Psychological, biological, social, and environmental factors can contribute to substance use disorders. In recent years, neuroimaging breakthroughs have helped elucidate the mechanisms of substance misuse and its effects on the brain. Functional magnetic resonance imaging (MRI), positron emission tomography (PET), single-photon emission computed tomography (SPECT), and magnetic resonance spectroscopy (MRS) are all examples. Neuroimaging studies suggest substance misuse affects executive function, reward, memory, and stress systems. Recent neuroimaging research attempts have provided clinicians with improved tools to diagnose patients who misuse substances, comprehend the complicated neuroanatomy and neurobiology involved, and devise individually tailored and monitorable treatment regimens for individuals with substance use disorders. This review describes the most recent developments in drug misuse neuroimaging, including the neurobiology of substance use disorders, neuroimaging, and substance use disorders, established neuroimaging techniques, recent developments with established neuroimaging techniques and substance use disorders, and emerging clinical neuroimaging technology.


Item Type
Article
Publication Type
International, Open Access, Review, Article
Drug Type
All substances
Intervention Type
Screening / Assessment
Date
2023
Identification #
doi: 10.2147/SAR.S362861
Page Range
pp. 99-111
Publisher
Dove Press
Volume
14
EndNote

Repository Staff Only: item control page